Gene therapy could be cure for childhood blindness

A revolutionary technique for inserting healthy genes into unhealthy organs is to be extended to treat childhood blindness and Parkinson's disease.

British scientists are to pioneer the development of gene therapy for chronic and incurable conditions by announcing the first clinical trials on the eye and brain beginning next year.

Professor Robin Ali, head of the gene therapy team at the Institute of Ophthalmology, University College London, said animal tests had shown the approach could lead to an effective treatment for inherited blindness in children and visual deterioration in the elderly.

"There are lots of disorders of the eye that may be very amenable to this sort of novel treatment. There are a lot of eye diseases at present that are not effectively treated, or not treated at all," Professor Ali said. "We and a number of groups around the world have demonstrated proof of principle in a range of animals models for a variety of conditions. So we are now at the stage of seriously considering [clinical] trials."

A second team of scientists is preparing for gene therapy on patients suffering from advanced Parkinson's disease, which is caused by the degeneration of cells in the brain that produce the neurotransmitter dopamine.

Professor Alan Kingsman of Oxford University said he hoped to recruit 10 patients with an advanced disease for a trial to begin early next year. He has set up company called Oxford Biomedica to develop the research. "We have a product that turns cells that don't make dopamine into cells that do. You simply recreate the factory for dopamine. It works extremely well in animal models," Professor Kingsman said.

Gene therapy involves the creation of an artificial human gene that is inserted into the cells of the body by a "vector", which is usually a genetically engineered virus that has been rendered safe. "In Parkinson's, you effectively lose your dopamine factory. What you can do with gene therapy is essentially to deliver the genes that programme cells to make dopamine," he said.

Although initial gene therapy trials on other disorders proved unsuccessful, scientists have recently announced that they have worked well in treating some conditions, notably in babies born with defective immune systems. Now medical researchers want to extend the technique to include not just inherited diseases caused by defective genes, but disorders of later life that have proved difficult to treat by more conventional approaches.

Professor Ali said two trials were being planned, one to treat age-related macular degeneration, when the growth of blood vessels in the eye causes gradual blindness in the over-60s, and inherited blindness in children caused by a defect in a gene resulting in retinitis pigmentosa.

"In the main, to treat the inherited disorder we need to correct the underlying genetic defect, in the case of retinitis pigmentosa, perhaps putting the missing gene back into the photoreceptor cell," Professor Ali said. "Whereas in the case of more complex diseases of the elderly, the approach is usually to try to ameliorate some prominent feature of the disease without treating the underlying genetic defect."

"The major prerequisites for clinical trials have now been established so we can achieve very efficient gene transfer to the eye and achieve life-long gene expression without doing anything toxic. The potential outcome - and we'll have to wait to see whether it is borne out - would be improved night vision and improved peripheral vision. We would be able to determine this very quickly, within a few weeks of treatment."

Professor Ali said a key consideration was to assess the potential benefits of gene therapy compared with the risk of a child losing what little vision he or she may have.

"There is no way we'd undertake a clinical trial if we thought we were seriously risking a child's residual sight," he said.

Suggested Topics
Life and Style
ebookNow available in paperback
ebooks
ebookA delicious collection of 50 meaty main courses
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Recruitment Genius: 3rd Line Virtualisation, Windows & Server Engineer

    £40000 - £47000 per annum: Recruitment Genius: A 3rd Line Virtualisation / Sto...

    Recruitment Genius: Refrigeration and Air Conditioning Service Engineer

    £26000 - £35000 per annum: Recruitment Genius: A successful national service f...

    Recruitment Genius: Business Development Executive / Sales - OTE £25,000

    £15000 - £25000 per annum: Recruitment Genius: This is an opportunity to join ...

    Recruitment Genius: Sales Administrator - Fixed Term Contract

    £17500 - £20000 per annum: Recruitment Genius: We currently require an experie...

    Day In a Page

    Sepp Blatter resignation: The beginning of Fifa's long road to reform?

    Does Blatter's departure mean Fifa will automatically clean up its act?

    Don't bet on it, says Tom Peck
    Charles Kennedy: The baby of the House who grew into a Lib Dem giant

    The baby of the House who grew into a Lib Dem giant

    Charles Kennedy was consistently a man of the centre-left, dedicated to social justice, but was also a champion of liberty and an opponent of the nanny-state, says Baroness Williams
    Syria civil war: The harrowing testament of a five-year-old victim of this endless conflict

    The harrowing testament of a five-year-old victim of Syria's endless civil war

    Sahar Qanbar lost her mother and brother as civilians and government soldiers fought side by side after being surrounded by brutal Islamist fighters. Robert Fisk visited her
    The future of songwriting: How streaming is changing everything we know about making music

    The future of songwriting

    How streaming is changing everything we know about making music
    William Shemin and Henry Johnson: Jewish and black soldiers receive World War I Medal of Honor amid claims of discrimination

    Recognition at long last

    Jewish and black soldiers who fought in WWI finally receive medals after claims of discrimination
    Beating obesity: The new pacemaker which helps over-eaters

    Beating obesity

    The new pacemaker which helps over-eaters
    9 best women's festival waterproofs

    Ready for rain: 9 best women's festival waterproofs

    These are the macs to keep your denim dry and your hair frizz-free(ish)
    Cycling World Hour Record: Nervous Sir Bradley Wiggins ready for pain as he prepares to go distance

    Wiggins worried

    Nervous Sir Bradley ready for pain as he prepares to attempt cycling's World Hour Record
    Liverpool close in on Milner signing

    Liverpool close in on Milner signing

    Reds baulk at Christian Benteke £32.5m release clause
    On your feet! Spending at least two hours a day standing reduces the risk of heart attacks, cancer and diabetes, according to new research

    On your feet!

    Spending half the day standing 'reduces risk of heart attacks and cancer'
    With scores of surgeries closing, what hope is there for the David Cameron's promise of 5,000 more GPs and a 24/7 NHS?

    The big NHS question

    Why are there so few new GPs when so many want to study medicine?
    Big knickers are back: Thongs ain't what they used to be

    Thongs ain't what they used to be

    Big knickers are back
    Thurston Moore interview

    Thurston Moore interview

    On living in London, Sonic Youth and musical memoirs
    In full bloom

    In full bloom

    Floral print womenswear
    From leading man to Elephant Man, Bradley Cooper is terrific

    From leading man to Elephant Man

    Bradley Cooper is terrific